Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004974948 | SCV005579840 | uncertain significance | Inborn genetic diseases | 2024-12-04 | criteria provided, single submitter | clinical testing | The c.9565G>A (p.D3189N) alteration is located in exon 9 (coding exon 9) of the FAT4 gene. This alteration results from a G to A substitution at nucleotide position 9565, causing the aspartic acid (D) at amino acid position 3189 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005023765 | SCV005657513 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-02-19 | criteria provided, single submitter | clinical testing |